Pharma Payments to Mental Health Group: More to Come? - Health Blog - WSJ

Image by Getty Images via Daylife

By Jacob Goldstein

Over the past few years, the drug industry contributed more than $20 million to the nonprofit advocacy group National Alliance on Mental Illness. That figure was unearthed by Chuck Grassley, the Senator behind the never-ending inquiry into the drug industry’s financial ties, and reported this week in the New York Times.

Now Grassley wants to know how much drug makers contributed to state chapters of NAMI, Dow Jones Newswires reports.
Continue Reading

Related articles by Zemanta

• Drug Makers Are Advocacy Group's Biggest Donors (nytimes.com)